Free PMHNP-BC Practice Questions (With Rationales)

.spoke-cta{margin:24px 0}a.btn-join{display:inline-block;background:#2b6cb0;color:#fff!important;padding:12px 20px;border-radius:8px;font-weight:600;text-decoration:none;line-height:1.4}.spoke-q>li{margin:0 0 22px}.spoke-q ul{margin:6px 0 6px 18px}.spoke-table{border-collapse:collapse;width:100%;margin:18px 0}.spoke-table th,.spoke-table td{border:1px solid #d6dee8;padding:8px 12px;text-align:left;vertical-align:top}.spoke-table thead th{background:#f0f5fa}.spoke-sources{margin-top:32px;padding-top:16px;border-top:1px solid #e2e8f0;font-size:.92em;color:#4a5568}.spoke-sources a{word-break:break-word}

See where you stand before you buy. These sample questions match the ANCC
PMHNP-BC style — scenario-based, single best answer, with a rationale that explains the
reasoning. Work each one before reading the answer.

Unlock 2,600+ PMHNP-BC practice questions across 14 full-length simulators — $19.99 lifetime →

How close are these to the real PMHNP-BC exam?

The PMHNP-BC is 200 questions (175 scored) over 4 hours, weighted toward advanced practice skills,
diagnosis and treatment, and the scientific foundation — with psychopharmacology running
throughout. The samples below reflect that.

Sample PMHNP-BC questions

  1. A patient on lithium presents with coarse tremor, ataxia, vomiting, and confusion. The
    priority action is to:

    • A. Increase the lithium dose
    • B. Hold lithium and obtain a lithium level
    • C. Add an SSRI
    • D. Reassure and continue

    Answer: B. Those are signs of lithium toxicity. Hold the drug and check a level
    — lithium has a narrow therapeutic index (about 0.6–1.2 mEq/L), and toxicity can be
    life-threatening.

  2. Which monitoring is essential for a patient started on clozapine?
    • A. Liver enzymes only
    • B. Absolute neutrophil count (ANC)
    • C. Thyroid panel
    • D. No special monitoring

    Answer: B. Clozapine can cause severe neutropenia/agranulocytosis, so ANC
    monitoring is mandatory through a REMS program. It’s reserved for treatment-resistant cases for this reason.

  3. A patient with bipolar disorder is in a depressive episode. Prescribing an antidepressant
    alone risks:

    • A. Serotonin deficiency
    • B. Inducing mania or rapid cycling
    • C. Hypothyroidism
    • D. No particular risk

    Answer: B. Antidepressant monotherapy in bipolar disorder can trigger a manic
    switch or rapid cycling; a mood stabilizer is the foundation of treatment.

  4. A patient on an SSRI who is also taking a triptan and tramadol develops agitation,
    hyperthermia, clonus, and diaphoresis. This suggests:

    • A. Neuroleptic malignant syndrome
    • B. Serotonin syndrome
    • C. Anticholinergic toxicity
    • D. Lithium toxicity

    Answer: B. Multiple serotonergic agents plus hyperthermia, clonus, and autonomic
    signs point to serotonin syndrome. Stop the serotonergic drugs and provide supportive care.

  5. Long-term use of a first-generation (typical) antipsychotic carries the highest risk of:
    • A. Weight gain and diabetes
    • B. Tardive dyskinesia and extrapyramidal symptoms
    • C. Agranulocytosis
    • D. QT shortening

    Answer: B. Typical antipsychotics carry a higher risk of EPS and tardive
    dyskinesia; atypicals are more associated with metabolic effects (A). Matching side-effect profiles
    to agents is high-yield.

How did you do?

If the psychopharmacology felt shaky, that’s what practice is for. Our bank has 2,600+ PMHNP-BC
questions across 14 timed simulators with rationales like these, plus a free sample test.

Unlock 2,600+ PMHNP-BC practice questions across 14 full-length simulators — $19.99 lifetime →

Sources & references

The exam facts on this page are drawn from official certifying-body materials, reviewed 2026-06-18 by the DrCertifications exam-prep team (10+ years in exam preparation and publishing).